gthp has global sales and they don't have fda approval. scie has fda approval and no sales U.S. or global. why no sales?
doesn't look like people are expecting sales with a SP of less than 2 cents. Mngmnt should tell us status of sales as a reason why we should buy the stock. Product sounds exciting with potential large market. What gives?
thinking same. added at .47 which increased position by 50 percent
real risk is that partner may decide not to do phase 2. that would be very bad, then all that appears to be left is B12 good luck
Seems reasonable as to what happened. Stated a PR was coming out very soon explaining what happened. Also unrelated glitch in website being fixed.
there is nothing here. There oral insulin pill is based on EMIS Eligen technoloy. EMIS is currently 72 cents.and if there is a fundamental reason for ormp's move, EMIS should go to 20 bucks. That's why this whole thing appears manipulated
I assume Emis would get a royalty, as well as validation of their technology.
lots of hype on ormp;s insulin pill using Eligen tech from Emis. Ormp getting lots of play, traders on ormp obviously havenot figured out emis is the real play
like to know who bought what
not sure I agree, tho think very close. this decline continues as all moving avg broken, save the 200. Kramer called for biotech correction which has hastened the fall. I am a buyer should be support near 2.90 may get there soon, then a bounce polymedix said brilacidin effective against Malaria, leo should comment
Any data on steel demand pickup? Moreover, only important if it translates into higher prices per metric ton of met coal. Consensus is the market seems to have bottomed and outlook is improving in latter half of year and next year. Problem is whether they can hang on long enough,
decline based on numbers leak? hard to tell. don't think bk is coming yet. So how far down?
two thirds retrace of recent move is complete at 60 cents. So believe it or not it's possible this move down was entirely technical exacerbated by the timely Seeking Alpha article. Lots of decisions will be made Tuesday..
The Chinese are proving to be very good capitalists.
Why this can be a 30 bagger.
Rarely do you ever see all 3 criteria in one stock:
1. One of a kind state of the art technology with no competition. Early detection is key and nothing is better. This is bigger than mammograms; and we are near a surge in genetic testing and that is only going to facilitate their business.
2. Enormous market
3. Low cap, only 24 million shares out currently. Even with future dilution still a microcap.
Sales numbers were low due to 2 factors
1. They virtually stopped trying to sell the approved aspirator as they were anticipating the 2nd would be approved.
2. Lack of distribution which is now remedied